JSKN022 in Subjects With Advanced Malignant Solid Tumors

NCT07292402 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: JSKN022

Sponsor

Jiangsu Alphamab Biopharmaceuticals Co., Ltd